Synthetic Human Antibody Library for Broad Target Screening

Monoclonal antibody therapeutics are among the most successful drug classes, yet traditional discovery methods rely on immunisation or donor-derived B-cell repertoires. These approaches can be slow, ethically constrained, and limited in diversity.

Synthetic antibody libraries provide a renewable and fully human source of high-affinity binders for therapeutic and diagnostic applications.

Developed using structurally validated human frameworks and rationally engineered CDR diversity, the library delivers high-quality, fully human binders with improved stability and expression. It is compatible with phage, yeast, and mammalian display systems, enabling efficient screening against diverse and complex targets, including GPCRs.